{"created":"2023-05-15T15:02:32.550650+00:00","id":84802,"links":{},"metadata":{"_buckets":{"deposit":"5f76f26a-314b-48e3-9cd2-4b855b3ed642"},"_deposit":{"created_by":1,"id":"84802","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"84802"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00084802","sets":["1"]},"author_link":["1023243","1023242","1023238","1023236","1023240","1023233","1023237","1023244","1023241","1023239","1023234","1023235"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"6076","bibliographicPageStart":"6067-6076","bibliographicVolumeNumber":"41","bibliographic_titles":[{"bibliographic_title":"Anticancer Research"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"We describe a pharmacological strategy for selectively targeting glioblastoma using a redox-active combination drug menadione/ascorbate (M/A), compared to the chemotherapeutic standard-of-care temozolomide (TMZ).","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"International Institute of Anticancer Research"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"34848461","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.21873/anticanres.15426","subitem_relation_type_select":"DOI"}}]},"item_8_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://ar.iiarjournals.org/content/41/12/6067.long","subitem_relation_type_select":"URI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0250-7005","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Sumiyoshi, Akira"}],"nameIdentifiers":[{"nameIdentifier":"1023233","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shibata, Sayaka"}],"nameIdentifiers":[{"nameIdentifier":"1023234","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Zhelev, Zhivko"}],"nameIdentifiers":[{"nameIdentifier":"1023235","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Miller, Thomas"}],"nameIdentifiers":[{"nameIdentifier":"1023236","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Lazarova, Dessislava"}],"nameIdentifiers":[{"nameIdentifier":"1023237","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Zlateva, Genoveva"}],"nameIdentifiers":[{"nameIdentifier":"1023238","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Aoki, Ichio"}],"nameIdentifiers":[{"nameIdentifier":"1023239","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Bakalova, Rumiana"}],"nameIdentifiers":[{"nameIdentifier":"1023240","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Akira, Sumiyoshi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1023241","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sayaka, Shibata","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1023242","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ichio, Aoki","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1023243","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Bakalova, Rumiana","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"1023244","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide."}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-12-23"},"publish_date":"2021-12-23","publish_status":"0","recid":"84802","relation_version_is_last":true,"title":["Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T18:11:20.136566+00:00"}